Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

The Relapse Mechanisms and Genomic Landscape Differ in KMT2A -r Pediatric Leukemia in Relation to Relapse Time

Louise Ahlgren, Mattias Pilheden, Helena Sturesson, Varsha Singh, Qirui Zhang, Michael Walsh, Guangchun Song, Anders Castor, Cornelis Jan Pronk, Pauline Schneider, Ronald W. Stam, Gisela Barbany, Katja Pokrovskaja Tamm, Jonas Abrahamsson, Linda Fogelstrand, Olli Lohi, Jing Ma, Jinghui Zhang, Anna K. Hagstroem-Andersson

Blood (2023) 142 (Supplement 1): 2978.

https://doi.org/10.1182/blood-2023-185044

Published: 2023

Journal Articles

Establishment and Characterization of a Model of Acquired Resistance to DOT1L Inhibition in KMT2A -Rearranged Acute Lymphoblastic Leukemia Cells

Pauline Schneider, Susan T.C.J.M. Arentsen-Peters, Nicholas T. Crump, Alastair Smith, Rico Hagelaar, Fabienne R.S. Adriaanse, Romy S. Bos, Kirsten S. Vrenken, Dedeke rockx-Brouwer, Ziqin Tang, Wilbert P. Vermeij, Anja De Jong, Bianca Koopmans, M.Emmy M. Dolman, Thomas A. Milne, Rob Pieters, Ronald W. Stam

Blood (2022) 140 (Supplement 1): 8760–8761.

https://doi.org/10.1182/blood-2022-166310

Published: 2022

Journal Articles

Single Cell Transcriptomics Predicts Relapse in Infants with Acute Lymphoblastic Leukemia

Tito Candelli, PhD, Pauline Schneider, Patricia Garrido Castro, PhD, Luke A Jones, PhD, Rob Pieters, MDPhDMSc, Thanasis Margaritis, PhD, Ronald W. Stam, PhD, Frank C.P. Holstege, PhD

Blood (2019) 134 (Supplement_1): 3951.

https://doi.org/10.1182/blood-2019-123052

Published: 2019

Journal Articles

Irinotecan Induces Complete Remission in MLL -Rearranged Acute Lymphoblastic Leukemia Xenografts

Patricia Garrido Castro, PhD, Mark Kerstjens, MSc, Sandra S Pinhanços, MSc, Pauline Schneider, BSc, Priscilla Wander, MSc, Rob Pieters, MD PhD, Ronald Stam, PhD

Blood (2017) 130 (Supplement 1): 3877.

https://doi.org/10.1182/blood.V130.Suppl_1.3877.3877

Published: 2017

Journal Articles

Unravelling the Mirnome of MLL -Rearranged Acute Lymphoblastic Leukemia

Patricia Garrido Castro, PhD, Clara Bueno, PhD, Eddy HJ van Roon, PhD, Sandra S Mimoso Pinhancos, MSc, Pauline Schneider, BSc, Merel Willekes, BSc, Pablo Menendez, PhD, Rob Pieters, MD PhD, Ronald Stam, PhD

Blood (2014) 124 (21): 878.

https://doi.org/10.1182/blood.V124.21.878.878

Published: 2014

Journal Articles

The Histone Deacetylase Inhibitor Panobinostat (LBH-589) Exerts Anti-Leukaemic Activity in a MLL-Rearranged ALL Xenograft Mouse Model

Patricia Garrido Castro, PhD, Eddy HJ Van Roon, PhD, Sandra S Mimoso Pinhancos, MSc, Pauline Schneider, BSc, Mark JB Kerstjens, MSc, Merel Willekes, BSc, Rob Pieters, MD PhD, Ronald Stam, PhD

Blood (2014) 124 (21): 3709.

https://doi.org/10.1182/blood.V124.21.3709.3709

Published: 2014

Journal Articles

MLL Fusion Driven Activation of CDK6 Potentiates Proliferation in MLL- rearranged Infant ALL

Marieke Hendrika van der Linden, Merel Willekes, Eddy Van Roon, PhD, Pauline Schneider, Rob Pieters, MD, PhD, Ronald Stam, PhD

Blood (2012) 120 (21): 1426.

https://doi.org/10.1182/blood.V120.21.1426.1426

Published: 2012

Journal Articles

MLL -Rearranged ALL Cells Are Highly Dependent On the Expression of EP300-Interacting Inhibitor of Differentiation 1 (EID1)

Marieke Hendrika van der Linden, Pauline Schneider, Rob Pieters, MD, PhD, Ronald Stam, PhD

Blood (2012) 120 (21): 1462.

https://doi.org/10.1182/blood.V120.21.1462.1462

Published: 2012

Journal Articles

Connectivity Mapping Identifies HDAC Inhibitors as Suitable Candidates for the Treatment of t(4;11)-Positive Acute Lymphoblastic Leukemia In Infants

Dominique JPM Stumpel, Pauline Schneider, Lidija Seslija, Hikari Osaki, Owen Williams, Rob Pieters, MD, PhD, Ronald Stam, PhD

Blood (2010) 116 (21): 3222.

https://doi.org/10.1182/blood.V116.21.3222.3222

Published: 2010

Journal Articles

Methylation of Specific Microrna Genes In MLL -Rearranged Infant Acute Lymphoblastic Leukemia: - Major Matters at a Micro Scale -

Dominique JPM Stumpel, Diana Schotte, Ellen AM Lange-Turenhout, Pauline Schneider, Lidija Seslija, Renee X de Menezes, Victor E Marquez, Rob Pieters, MD, PhD, Monique L. Den Boer, Ronald Stam, PhD

Blood (2010) 116 (21): 2483.

https://doi.org/10.1182/blood.V116.21.2483.2483

Published: 2010

Journal Articles

Gene expression profiling–based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants

Ronald W. Stam, Pauline Schneider, Jill A. P. Hagelstein, Marieke H. van der Linden, Dominique J. P. M. Stumpel, Renee X. de Menezes, Paola de Lorenzo, Maria G. Valsecchi, Rob Pieters

Blood (2010) 115 (14): 2835–2844.

https://doi.org/10.1182/blood-2009-07-233049

Published: 2010

Includes: Supplemental data

Journal Articles

Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL -rearranged infant acute lymphoblastic leukemia

Ronald W. Stam, Monique L. Den Boer, Pauline Schneider, Jasper de Boer, Jill Hagelstein, Maria G. Valsecchi, Paola de Lorenzo, Stephen E. Sallan, Hugh J. M. Brady, Scott A. Armstrong, Rob Pieters

Blood (2010) 115 (5): 1018–1025.

https://doi.org/10.1182/blood-2009-02-205963

Published: 2010

Journal Articles

Specific promoter methylation identifies different subgroups of MLL -rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options

Dominique J. P. M. Stumpel, Pauline Schneider, Eddy H. J. van Roon, Judith M. Boer, Paola de Lorenzo, Maria G. Valsecchi, Renee X. de Menezes, Rob Pieters, Ronald W. Stam

Blood (2009) 114 (27): 5490–5498.

https://doi.org/10.1182/blood-2009-06-227660

Published: 2009

Includes: Supplemental data

Journal Articles

High Expression of the Ca 2+ -Binding Proteins S100A8 and S100A9 Cause Glucocorticoid Resistance in MLL -Rearranged Infant Acute Lymphoblastic Leukemia.

Jill Hagelstein, Pauline Schneider, Jasper de Boer, Esther Hulleman, PhD, Owen Williams, Rob Pieters, Ronald W. Stam, Ph.D.

Blood (2009) 114 (22): 729.

https://doi.org/10.1182/blood.V114.22.729.729

Published: 2009

Journal Articles

Rearranged Infant Acute Lymphoblastic Leukemia.

Ronald W. Stam, PhD, Monique L. Den Boer, PhD, Pauline Schneider, Jasper de Boer, PhD, Jill Hagelstein, MSc, Stephen E. Sallan, MD, Hugh J.M. Brady, PhD, Scott Armstrong, MD, PhD, Rob Pieters, MD, PhD

Blood (2008) 112 (11): 1913.

https://doi.org/10.1182/blood.V112.11.1913.1913

Published: 2008

Journal Articles

Specific Promoter CpG Island Methylation Patterns Identify Different Subgroups of MLL - Rearranged Infant Acute Lymphoblastic Leukemia, and Define Clinical Outcome

Dominique Jpm Stumpel, MD, Pauline Schneider, Eddy HJ van Roon, MSc, Judith M Boer, PhD, Renee X Menezes, PhD, Rob Pieters, MD, PhD, Ronald W. Stam, Ph.D.

Blood (2008) 112 (11): 596.

https://doi.org/10.1182/blood.V112.11.596.596

Published: 2008

Journal Articles

Distinct Methylation Patterns among Infants with MLL Rearranged Acute Lymphoblastic Leukemia.

Dominique J.P.M. Stumpel, MD, Pauline Schneider, BSc, Eddy H.J. van Roon, MSc, Judith M. Boer, PhD, Renee X. Menezes, PhD, Rob Pieters, MD, PhD, Ronald W. Stam, PhD

Blood (2007) 110 (11): 2794.

https://doi.org/10.1182/blood.V110.11.2794.2794

Published: 2007

Journal Articles

Prognostic significance of high-level FLT3 expression in MLL -rearranged infant acute lymphoblastic leukemia

Ronald W. Stam, Pauline Schneider, Paola de Lorenzo, Maria G. Valsecchi, Monique L. den Boer, Rob Pieters

Blood (2007) 110 (7): 2774–2775.

https://doi.org/10.1182/blood-2007-05-091934

Published: 2007

Journal Articles

No Evidence for Constitutively Activated FLT3 in Juvenile Myelo-Monocytic Leukemia.

Andrica C.H. de Vries, MD, Ronald W. Stam, Pauline Schneider, Charlotte M. Niemeyer, MD, PhD, Elisabeth R. van Wering, MD, Christian Kratz, MD, PhD, Oskar A. Haas, PhD, Monique L. den Boer, PhD, Rob Pieters, MD, PhD, Marry M. van den Heuvel-Eibrink, MD, PhD

Blood (2005) 106 (11): 4915.

https://doi.org/10.1182/blood.V106.11.4915.4915

Published: 2005

Journal Articles

Targeting FLT3 in primary MLL -gene–rearranged infant acute lymphoblastic leukemia

Ronald W. Stam, Monique L. den Boer, Pauline Schneider, Peter Nollau, Martin Horstmann, H. Berna Beverloo, Ella van der Voort, Maria G. Valsecchi, Paola de Lorenzo, Stephen E. Sallan, Scott A. Armstrong, Rob Pieters

Blood (2005) 106 (7): 2484–2490.

https://doi.org/10.1182/blood-2004-09-3667

Published: 2005

NARROW

The Relapse Mechanisms and Genomic Landscape Differ in KMT2A -r Pediatric Leukemia in Relation to Relapse Time

Establishment and Characterization of a Model of Acquired Resistance to DOT1L Inhibition in KMT2A -Rearranged Acute Lymphoblastic Leukemia Cells

Single Cell Transcriptomics Predicts Relapse in Infants with Acute Lymphoblastic Leukemia

Irinotecan Induces Complete Remission in MLL -Rearranged Acute Lymphoblastic Leukemia Xenografts

Unravelling the Mirnome of MLL -Rearranged Acute Lymphoblastic Leukemia

The Histone Deacetylase Inhibitor Panobinostat (LBH-589) Exerts Anti-Leukaemic Activity in a MLL-Rearranged ALL Xenograft Mouse Model

MLL Fusion Driven Activation of CDK6 Potentiates Proliferation in MLL- rearranged Infant ALL

MLL -Rearranged ALL Cells Are Highly Dependent On the Expression of EP300-Interacting Inhibitor of Differentiation 1 (EID1)

Connectivity Mapping Identifies HDAC Inhibitors as Suitable Candidates for the Treatment of t(4;11)-Positive Acute Lymphoblastic Leukemia In Infants

Methylation of Specific Microrna Genes In MLL -Rearranged Infant Acute Lymphoblastic Leukemia: - Major Matters at a Micro Scale -

Gene expression profiling–based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants

Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL -rearranged infant acute lymphoblastic leukemia

Specific promoter methylation identifies different subgroups of MLL -rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options

High Expression of the Ca 2+ -Binding Proteins S100A8 and S100A9 Cause Glucocorticoid Resistance in MLL -Rearranged Infant Acute Lymphoblastic Leukemia.

Rearranged Infant Acute Lymphoblastic Leukemia.

Specific Promoter CpG Island Methylation Patterns Identify Different Subgroups of MLL - Rearranged Infant Acute Lymphoblastic Leukemia, and Define Clinical Outcome

Distinct Methylation Patterns among Infants with MLL Rearranged Acute Lymphoblastic Leukemia.

Prognostic significance of high-level FLT3 expression in MLL -rearranged infant acute lymphoblastic leukemia

No Evidence for Constitutively Activated FLT3 in Juvenile Myelo-Monocytic Leukemia.

Targeting FLT3 in primary MLL -gene–rearranged infant acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only